dcterms.isReferencedBy |
Raymond, D.P., Pelletier, S.J., Crabtree, T.D., Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients (2003) Crit Care Med, 31 (4), pp. 1035-1041; Laxminarayan, R., Zulfiqar, B., Adrian, D., Drug Resistance (2006), pp. 1034-1051. , In: Jamison, editor. Disease Control Priorities in Developing Countries. New York: Oxford University Press; Yalcin, A.N., Hayran, M., Unal, S., Economic analysis of nosocomial infections in a Turkish university hospital (1997) J Chemother, 9 (6), pp. 411-414; Llor, C., Cots, J.M., The sale of antibiotics without prescription in pharmacies in Catalonia, Spain (2009) Clin Infect Dis, 15 (10), pp. 1345-1349; Grigoryan, L., Haaijer-ruskamp, F.M., Burgerhof, J.G., Self-medication with antimicrobial drugs in Europe (2006) Emerg Infect Dis, 12 (3), pp. 452-459; Goossens, H., Guillemot, D., Ferech, M., National campaigns to improve antibiotic use (2006) Eur J Clin Pharmacol, 62 (5), pp. 373-379; Sabuncu, E., David, J., Bernede-bauduin, C., Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007 (2009) PLoS Med, 6 (6); Awad, A., Eltayeb, I., Matowe, L., Self-medication with antibiotics and antimalarials in the community of Khartoum State, Sudan (2005) J Pharm Pharm Sci, 8 (2), pp. 326-331; Mwambete, K.D., Irrational antibiotic usage in boarding secondary school settings in Dar es Salaam (2009) East Afr J Public Health, 6 (2), pp. 200-204; Abasaeed, A., Vlcek, J., Abuelkhair, M., Self-medication with antibiotics by the community of Abu Dhabi Emirate, United Arab Emirates (2009) J Infect Dev Ctries, 3 (7), pp. 491-497; Al-azzam, S.I., Al-husein, B.A., Alzoubi, F., Self-medication with antibiotics in Jordanian population (2007) Int J Occup Med Environ Health, 20 (4), pp. 373-380; Al-bakri, A.G., Bustanji, Y., Yousef, A.M., Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness (2005) Int J Antimicrob Agents, 26 (5), pp. 389-395; Earnshaw, S., Monnet, D.L., Duncan, B., European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries (2009) Euro Surveill, 14 (30), p. 19280; Nsubuga, P., Mark, E.W., Stephen, B.T., Public Health Surveillance: A Tool for Targeting and Monitoring Interventions (2006), pp. 997-1015. , In: Jamison, editor. Disease Control Priorities in Developing Countries: New York: Oxford University press; El Kholy, A., Baseem, H., Hall, G.S., Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals (2003) J Antimicrob Chemother, 2000 (3), pp. 625-630; Bouchillon, S.K., Johnson, B.M., Hoban, D.J., Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002 (2004) Int J Antimicrob Agents, 24 (2), pp. 119-124; Borg, M.A., Scicluna, E., de Kraker, M., Antibiotic resistance in the southeastern Mediterranean--preliminary results from the ARMed project (2006) Euro Surveill, 11 (7), pp. 164-167; Borg, M.A., de Kraker, M., Scicluna, E., Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries (2007) J Antimicrob Chemother, 60 (6), pp. 1310-1315; Borg, M.A., van de Sande-bruinsma, N., Scicluna, E., Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories (2008) Clin Microbiol Infect, 14 (8), pp. 789-796; Gad, G.F., El-domany, R.A., Zaki, S., Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms (2007) J Antimicrob Chemother, 60 (5), pp. 1010-1017; Ramdani-bouguessa, N., Bes, M., Meugnier, H., Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital (2006) Antimicrob Agents Chemother, 50 (3), pp. 1083-1085; Ben Jemaa, Z., Mahjoubi, F., Ben Haj H'mida, Y., Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Sfax-Tunisia (1993-1998) (2004) Pathol Biol, 52 (2), pp. 82-88. , (Paris); Al-zu'bi, E., Bdour, S., Shehabi, A.A., Antibiotic resistance patterns of mecA-positive Staphylococcus aureus isolates from clinical specimens and nasal carriage (2004) Microb Drug Resist, 10 (4), pp. 321-324; Kanj, S.S., Ghaleb, P.A., Araj, G.F., Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon (2004) J Med Liban, 52 (1), pp. 8-12; Ahmed, M.M., Bahlas, S., Bacteriological profile and antimicrobial resistance patterns of clinical bacterial isolates in a University Hospital (2009) Travel Med Infect Dis, 7 (4), pp. 235-238; Utsui, Y., Yokota, T., Role of an altered penicillin-binding protein in methicillin-and cephem-resistant Staphylococcus aureus (1985) Antimicrob Agents Chemother, 28, pp. 397-403; Ma, X.X., Ito, T., Tiensasitorn, C., Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains (2002) Antimicrob Agents Chemother, 46, pp. 1147-1152; Deurenberg, R.H.C.V., Kalenic, S., Friedrich, A.W., The molecular evolution of methicillin-resistant Staphylococcus aureus (2007) Clin Microbiol Infect, 13, pp. 222-235; Wisplinghoff, H., Rosato, A.E., Enright, M.C., Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates (2003) Antimicrob Agents Chemother, 47 (11), pp. 3574-3579; Boucher, H.W., Corey, G.R., Epidemiology of methicillin-resistant Staphylococcus aureus (2008) Clin Infect Dis, 1 (SUPPL. 5), pp. S344-9; Vandenesch, F., Naimi, T., Enright, M.C., Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence (2003) Emerg Infect Dis, 9 (8), pp. 978-984; Enany, S., Higuchi, W., Okubo, T., Brain abscess caused by Panton-Valentine leukocidin-positive communityacquired methicillin-resistant Staphylococcus aureus in Egypt, April 2007 (2007) Euro Surveill, 12 (9), pp. E070927.2; Enany, S., Yaoita, E., Yoshida, Y., Molecular characterization of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus isolates in Egypt (2010) Microbiol Res, 165 (2), pp. 152-162; El-sharif, A., Ashour, H.M., Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers (2008) Exp Biol Med, 233 (7), pp. 874-880. , (Maywood); Chongtrakool, P., Ito, T., Ma, X.X., Staphylococcal cassette chromosome mec (SCCmec) typing of methicillinresistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements (2006) Antimicrob Agents Chemother, 50 (3), pp. 1001-1012; Monnet, D.L., MacKenzie, F.M., Lopez-lozano, J.M., Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000 (2004) Emerg Infect Dis, 10 (8), pp. 1432-1441; Gur, D., Unal, S., Resistance to antimicrobial agents in Mediterranean countries (2001) Int J Antimicrob Agents, 17 (1), pp. 21-26; Borg, M.A., Zarb, P., Ferech, M., Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project (2008) J Antimicrob Chemother, 62 (4), pp. 830-836; Raveh, D., Levy, Y., Schlesinger, Y., Longitudinal surveillance of antibiotic use in the hospital (2001) Qjm., 94 (3), pp. 141-152; Borg, M.A., Cookson, B.D., Gur, D., Infection control and antibiotic stewardship practices reported by southeastern Mediterranean hospitals collaborating in the ARMed project (2008) J Hosp Infect, 70 (3), pp. 228-234; Narasimhan, V., Brown, H., Pablos-mendez, A., Responding to the global human resources crisis (2004) Lancet, 363 (9419), pp. 1469-1472; Amazian, K., Fendri, C., Missoum, M.F., Multicenter pilot survey of resistant bacteria in the Mediterranean area (2006) Eur J Clin Microbiol Infect Dis, 25 (5), pp. 340-343; Livermore, D.M., beta-Lactamases in laboratory and clinical resistance (1995) Clin Microbiol Rev., 8 (4), pp. 557-584; Ambler, R.P., Coulson, A.F., Frere, J.M., A standard numbering scheme for the class A beta-lactamases (1991) Biochem J, 15 (PART 1), pp. 269-270; Bush, K., Jacoby, G.A., Medeiros, A.A., A functional classification scheme for beta-lactamases and its correlation with molecular structure (1995) Antimicrob Agents Chemother, 39 (6), pp. 1211-1233; Hawkey, P.M., Molecular epidemiology of clinically significant antibiotic resistance genes (2008) Br J Pharmacol, 153 (SUPPL. 1), pp. S406-13; Giske, C.G., Sundsfjord, A.S., Kahlmeter, G., Redefining extended-spectrum beta-lactamases: balancing science and clinical need (2009) J Antimicrob Chemother, 63 (1), pp. 1-4; Poirel, L., Girlich, D., Naas, T., OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid-and integron-located gene (2001) Antimicrob Agents Chemother, 45 (2), pp. 447-453; Naas, T., Sougakoff, W., Casetta, A., Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa (1998) Antimicrob Agents Chemother, 42 (8), pp. 2074-2083; Toleman, M.A., Rolston, K., Jones, R.N., Molecular and biochemical characterization of OXA-45, an extendedspectrum class 2d' beta-lactamase in Pseudomonas aeruginosa (2003) Antimicrob Agents Chemother, 47 (9), pp. 2859-2863; Danel, F., Hall, L.M., Gur, D., OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain (1997) Antimicrob Agents Chemother, 41 (4), pp. 785-790; Poirel, L., Gerome, P., De Champs, C., Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 beta-lactamase from Pseudomonas aeruginosa (2002) Antimicrob Agents Chemother, 46 (2), pp. 566-569; Philippon, L.N., Naas, T., Bouthors, A.T., OXA-18, a class D clavulanic acid-inhibited extended-spectrum betalactamase from Pseudomonas aeruginosa (1997) Antimicrob Agents Chemother, 41 (10), pp. 2188-2195; Moore, K.L., Kainer, M.A., Badrawi, N., Neonatal sepsis in Egypt associated with bacterial contamination of glucose-containing intravenous fluids (2005) Pediatr Infect Dis J, 24 (7), pp. 590-594; Zaki Mel, S., Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience (2007) J Infect Dev Ctries, 1 (3), pp. 269-274; Shehabi, A.A., Baadran, I., Microbial infection and antibiotic resistance patterns among Jordanian intensive care patients (1996) Eastern Mediterran Health J, 2, pp. 515-520; Shehabi, A.A., Mahafzah, A., Baadran, I., High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units (2000) Diagn Microbiol Infect Dis, 36 (1), pp. 53-56; Panhotra, B.R., Saxena, A.K., Al-ghamdi, A.M., Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome (2004) Saudi Med J, 25 (12), pp. 1871-1876; El-khizzi, N.A., Bakheshwain, S.M., Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital (2006) Saudi Med J, 27 (1), pp. 37-40; Kader, A.A., Kumar, A., Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital (2005) Ann Saudi Med, 25 (3), pp. 239-242; Khanfar, H.S., Bindayna, K.M., Senok, A.C., Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings (2009) J Infect Dev Ctries, 3 (4), pp. 295-299; Paterson, D.L., Bonomo, R.A., Extended-spectrum beta-lactamases: a clinical update (2005) Clin Microbiol Rev, 18 (4), pp. 657-686; Bonnet, R., Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes (2004) Antimicrob Agents Chemother, 48 (1), pp. 1-14; Poirel, L., Gniadkowski, M., Nordmann, P., Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3 (2002) J Antimicrob Chemother, 50 (6), pp. 1031-1034; Pitout, J.D., Hossain, A., Hanson, N.D., Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp (2004) J Clin Microbiol, 42 (12), pp. 5715-5721; Moubareck, C., Daoud, Z., Hakime, N.I., Countrywide spread of community-and hospital-acquired extendedspectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon (2005) J Clin Microbiol, 43 (7), pp. 3309-3313; Touati, A., Benallaoua, S., Forte, D., First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Bejaia, Algeria (2006) Int J Antimicrob Agents, 27 (5), pp. 397-402; Mohamed Al-agamy, M.H., El-din Ashour, M.S., Wiegand, I., First description of CTX-M beta-lactamaseproducing clinical Escherichia coli isolates from Egypt (2006) Int J Antimicrob Agents, 27 (6), pp. 545-548; Mamlouk, K., Boutiba-ben Boubaker, I., Gautier, V., Emergence and outbreaks of CTX-M beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital (2006) J Clin Microbiol, 44 (11), pp. 4049-4056; Lavollay, M., Mamlouk, K., Frank, T., Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui (2006) Antimicrob Agents Chemother, 50 (7), pp. 2433-2438; Sonnevend, A., Al Dhaheri, K., Mag, T., CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates (2006) Clin Microbiol Infect, 12 (6), pp. 582-585; Moubareck, C., Doucet-populaire, F., Hamze, M., First extended-spectrum-beta-lactamase (CTX-M-15)-producing Salmonella enterica serotype typhimurium isolate identified in Lebanon (2005) Antimicrob Agents Chemother, 49 (2), pp. 864-865; Rotimi, V.O., Jamal, W., Pal, T., Emergence of CTX-M-15 type extended-spectrum beta-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates (2008) J Med Microbiol, 57 (PART 7), pp. 881-886; Khalaf, N.G., Eletreby, M.M., Hanson, N.D., Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt (2009) BMC Infect Dis, 9, p. 84; Ben Achour, N., Mercuri, P.S., Power, P., First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain (2009) Pathol Biol, 57 (5), pp. 343-348. , (Paris); Meradi, L., Djahoudi, A., Abdi, A., Qnr and aac (6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria (2009) Pathol Biol, , (Paris), Nov 4; Coque, T.M., Baquero, F., Canton, R., Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe (2008) Euro Surveill, 13 (47). , 20, pii: 19044; Livermore, D.M., Canton, R., Gniadkowski, M., CTX-M: changing the face of ESBLs in Europe (2007) J Antimicrob Chemother, 59 (2), pp. 165-174; Makanera, A., Arlet, G., Gautier, V., Molecular epidemiology and characterization of plasmid-encoded betalactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broadspectrum cephalosporins (2003) J Clin Microbiol, 41 (7), pp. 2940-2945; Ishida, Y., Ahmed, A.M., Mahfouz, N.B., Molecular Analysis of Antimicrobial Resistance in Gram-Negative Bacteria Isolated from Fish Farms in Egypt (2010) J Vet Med Sci, 72 (6), pp. 727-734; Iabadene, H., Messai, Y., Ammari, H., Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals (2009) Int J Antimicrob Agents, 34 (4), pp. 340-342; Abbassi, M.S., Torres, C., Achour, W., Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia (2008) Int J Antimicrob Agents, 32 (4), pp. 308-314; Mansour, W., Dahmen, S., Poirel, L., Emergence of SHV-2a extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a university hospital in Tunisia (2009) Microb Drug Resist, 15 (4), pp. 295-301; Hammami, S., Gautier, V., Ghozzi, R., Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis (2010) Clin Microbiol Infect, 16 (2), pp. 189-193; AbdelGhani, S.M., Moland, E.S., Black, J.A., First report of CTX-M-14 producing clinical isolates of Salmonella serovar Typhimurium from Egypt (2009) J Infect Dev Ctries, 4 (1), pp. 58-60; Abdel-hady, H., Hawas, S., El-daker, M., Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit (2008) J Perinatol, 28 (10), pp. 685-690; Ahmed, A.M., Younis, E.E., Ishida, Y., Genetic basis of multidrug resistance in Salmonella enterica serovars Enteritidis and Typhimurium isolated from diarrheic calves in Egypt (2009) Acta Trop, 111 (2), pp. 144-149; Elhani, D., Bakir, L., Aouni, M., Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005 (2010) Clin Microbiol Infect, 16 (2), pp. 157-164; Dahmen, S., Poirel, L., Mansour, W., Prevalence of plasmidmediated quinolone resistance determinants in Enterobacteriaceae from Tunisia (2009) Clin Microbiol Infect, 16 (7), pp. 1019-1023; Hussein, A.I., Ahmed, A.M., Sato, M., Characterization of integrons and antimicrobial resistance genes in clinical isolates of Gram-negative bacteria from Palestinian hospitals (2009) Microbiol Immunol, 53 (11), pp. 595-602; Nordmann, P., Naas, T., Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class-A beta-lactamases (1994) Antimicrob Agents Chemother, 38 (1), pp. 104-114; Vahaboglu, H., Ozturk, R., Aygun, G., Widespread detection of PER-1-type extended-spectrum betalactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study (1997) Antimicrob Agents Chemother, 41 (10), pp. 2265-2269; Iabadene, H., Dallenne, C., Messai, Y., Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria (2009) Antimicrob Agents Chemother, 53 (9), pp. 4043-4044; Rossolini, G.M., Franceschini, N., Lauretti, L., Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA (CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases (1999) Antimicrob Agents Chemother, 43 (9), pp. 2193-2199; Poirel, L., Naas, T., Guibert, M., Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene (1999) Antimicrob Agents Chemother, 43 (3), pp. 573-581; Aubert, D., Naas, T., Lartigue, M.F., Novel genetic structure associated with an extended-spectrum betalactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria (2005) Antimicrob Agents Chemother, 49 (8), pp. 3590-3592; Girlich, D., Naas, T., Leelaporn, A., Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand (2002) Clin Infect Dis, 1 (5), pp. 603-611; Khalaf, N.G., Moland, E.S., Thomson, (2007), Production of a Novel Extended Spectrum Beta Lactamase, VEB-5 in an E. coli Isolate from the United States.; GenBank Accession number EF420108; Woodford, N., Zhang, J., Kaufmann, M.E., Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom (2008) J Antimicrob Chemother, 62 (6), pp. 1265-1268; Mammeri, H., Van De Loo, M., Poirel, L., Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe (2005) Antimicrob Agents Chemother, 49 (1), pp. 71-76; Poirel, L., Van De Loo, M., Mammeri, H., Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1 (2005) Antimicrob Agents Chemother, 49 (7), pp. 3091-3094; Shahcheraghi, F., Badmasti, F., Feizabadi, M.M., Molecular characterization of class 1 integrons in MDR Pseudomonas aeruginosa isolated from clinical settings in Iran, Tehran (2010) FEMS Immunol Med Microbiol, 58 (3), pp. 421-425; Mirsalehian, A., Feizabadi, M., Nakhjavani, F.A., Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients (2010) Burns, 36 (1), pp. 70-74; Poirel, L., Rotimi, V.O., Mokaddas, E.M., VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait (2001) Emerg Infect Dis, 7 (3), pp. 468-470; Iabadene, H., Messai, Y., Ammari, H., Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria (2008) J Antimicrob Chemother, 62 (1), pp. 133-136; Kalai, B.S., Achour, W., Abbassi, M.S., Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia (2007) Clin Microbiol Infect, 13 (8), pp. 794-800; Kanj, S.S., Corkill, J.E., Kanafani, Z.A., Molecular characterisation of extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella spp. isolates at a tertiary-care centre in Lebanon (2008) Clin Microbiol Infect, 14 (5), pp. 501-504; Karim, A., Poirel, L., Nagarajan, S., Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1 (2001) FEMS Microbiol Lett, 24 (2), pp. 237-241; Sabate, M., Tarrago, R., Navarro, F., Cloning and sequence of the gene encoding a novel cefotaximehydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain (2000) Antimicrob Agents Chemother, 44 (7), pp. 1970-1973; Weill, F.X., Perrier-gros-claude, J.D., Demartin, M., Characterization of extended-spectrum-beta-lactamase (CTX-M-15)-producing strains of Salmonella enterica isolated in France and Senegal (2004) FEMS Microbiol Lett, 15 (2), pp. 353-358; Poirel, L., Lartigue, M.F., Decousser, J.W., ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli (2005) Antimicrob Agents Chemother, 49 (1), pp. 447-450; Messai, Y., Iabadene, H., Benhassine, T., Prevalence and characterization of extended-spectrum betalactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria) (2008) Pathol Biol, 56 (5), pp. 319-325. , (Paris); Clermont, O., Bonacorsi, S., Bingen, E., Rapid and simple determination of the Escherichia coli phylogenetic group (2000) Appl Environ Microbiol, 66 (10), pp. 4555-4558; Nicolas-chanoine, M.H., Blanco, J., Leflon-guibout, V., Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15 (2008) J Antimicrob Chemother, 25 (2), pp. 273-281; Coque, T.M., Novais, A., Carattoli, A., Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15 (2008) Emerg Infect Dis, 14 (2), pp. 195-200; Clermont, O., Lavollay, M., Vimont, S., The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup (2008) J Antimicrob Chemother, 61 (5), pp. 1024-1028; Jacoby, G.A., AmpC beta-lactamases (2009) Clin Microbiol Rev, 22 (1), pp. 161-182; Hanson, N.D., Thomson, K.S., Moland, E.S., (1999) J Antimicrob Chemother, 44 (3), pp. 377-380; Decre, D., Verdet, C., Raskine, L., Characterization of CMY-type beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area (2002) J Antimicrob Chemother, 50 (5), pp. 681-688; Moland, E.S., Hanson, N.D., Black, J.A., Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002 (2006) J Clin Microbiol, 44 (9), pp. 3318-3324; Hanson, N.D., Moland, E.S., Hossain, A., Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases (2002) J Antimicrob Chemother, 49 (6), pp. 1011-1014; Pitout, J.D., Reisbig, M.D., Mulvey, M., Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2 (2003) J Clin Microbiol, 41 (10), pp. 4578-4582; Moland, E.S., Black, J.A., Ourada, J., Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals (2002) Antimicrob Agents Chemother, 46 (12), pp. 3837-3842; Khalaf, N., Wiegand, I., Wiedemann, B., Detection of CMY-2 beta-lactamases in clinical P. stuartii isolates from Egypt (2004) R1962 ECCMID Prague; Queenan, A.M., Bush, K., Carbapenemases: the versatile beta-lactamases (2007) Clin Microbiol Rev, 20 (3), pp. 440-458; Yigit, H., Queenan, A.M., Anderson, G.J., Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae (2001) Antimicrob Agents Chemother, 45 (4), pp. 1151-1161; Yigit, H., Queenan, A.M., Rasheed, J.K., Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2 (2003) Antimicrob Agents Chemother, 47 (12), pp. 3881-3889; Naas, T., Cuzon, G., Villegas, M.V., Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene (2008) Antimicrob Agents Chemother, 52 (4), pp. 1257-1263; Nordmann, P., Poirel, L., Emerging carbapenemases in Gram-negative aerobes (2002) Clin Microbiol Infect, 8 (6), pp. 321-331; Al-agamy, M.H., Shibl, A.M., Tawfik, A.F., High prevalence of metallo-beta-lactamase-producing Pseudomonas aeruginosa from Saudi Arabia (2009) J Chemother, 21 (4), pp. 461-462; Mansour, W., Poirel, L., Bettaieb, D., Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia (2009) Diagn Microbiol Infect Dis, 64 (4), pp. 458-461; Guerin, F., Henegar, C., Spiridon, G., Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia (2005) J Antimicrob Chemother, 56 (3), pp. 601-602; Walther-rasmussen, J., Hoiby, N., OXA-type carbapenemases (2006) J Antimicrob Chemother, 57 (3), pp. 373-383; Mugnier, P.D., Bindayna, K.M., Poirel, L., Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain (2009) J Antimicrob Chemother, 63 (5), pp. 1071-1073; Mugnier, P., Poirel, L., Pitout, M., Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates (2008) Clin Microbiol Infect, 14 (9), pp. 879-882; Mansour, W., Poirel, L., Bettaieb, D., Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia (2008) Microb Drug Resist, 14 (4), pp. 289-292; Zarrilli, R., Vitale, D., Di Popolo, A., A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital (2008) Antimicrob Agents Chemother, 52 (11), pp. 4115-4120; Gur, D., Korten, V., Unal, S., Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites (2008) J Med Microbiol, 57 (PART 12), pp. 1529-1532; Feizabadi, M.M., Fathollahzadeh, B., Taherikalani, M., Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals (2008) Jpn J Infect Dis, 61 (4), pp. 274-278; Cuzon, G., Naas, T., Bogaerts, P., Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium (2008) Antimicrob Agents Chemother, 52 (9), pp. 3463-3464; Cuzon, G., Naas, T., Lesenne, A., Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia (2010) Int J Antimicrob Agents, 36 (1), pp. 91-93; Carrer, A., Poirel, L., Yilmaz, M., Spread of OXA-48-encoding plasmid in Turkey and beyond (2010) Antimicrob Agents Chemother, 54 (3), pp. 1369-1373; Matar, G.M., Dandache, I., Carrer, A., Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum beta-lactamase Ann Trop Med Parasitol, 104 (3), pp. 271-274; Aubert, D., Naas, T., Heritier, C., Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes (2006) J Bacteriol, 188 (18), pp. 6506-6514; Navon-venezia, S., Chmelnitsky, I., Leavitt, A., Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel (2006) Antimicrob Agents Chemother, 50 (9), pp. 3098-3101; Chmelnitsky, I., Navon-venezia, S., Strahilevitz, J., Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates (2008) Antimicrob Agents Chemother, 52 (8), pp. 2962-2965; Stapleton, P.D., Shannon, K.P., French, G.L., Carbapenem resistance in Escherichia coli associated with plasmiddetermined CMY-4 beta-lactamase production and loss of an outer membrane protein (1999) Antimicrob Agents Chemother, 43 (5), pp. 1206-1210; Bradford, P.A., Urban, C., Mariano, N., Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein (1997) Antimicrob Agents Chemother, 41 (3), pp. 563-569; Matar, G.M., Jaafar, R., Sabra, A., First detection and sequence analysis of the bla-CTX-M-15 gene in Lebanese isolates of extended-spectrum-beta-lactamase-producing Shigella sonnei (2007) Ann Trop Med Parasitol, 101 (6), pp. 511-517; Hooper, D.C., Mechanisms of fluoroquinolone resistance (1999) Drug Resist Updat, 2 (1), pp. 38-55; Hooper, D.C., Mechanisms of action and resistance of older and newer fluoroquinolones (2000) Clin Infect Dis, 31 (SUPPL. 2), pp. S24-28; Tran, J.H., Jacoby, G.A., Mechanism of plasmid-mediated quinolone resistance (2002), 99 (8), pp. 5638-5642. , Proc Natl Acad Sci U S A, Apr 16; Robicsek, A., Strahilevitz, J., Jacoby, G.A., Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase (2006) Nat Med, 12 (1), pp. 83-88; Wiegand, I., Khalaf, N., Al-agamy, M.H.M., First detection of the transferable quinolone resistance determinant in clinical Providencia stuartii strains in Egypt (2004), O347 ECCMID. Prague; Martinez-martinez, L., Pascual, A., Jacoby, G.A., Quinolone resistance from a transferable plasmid (1998) Lancet, 14 (9105), pp. 797-799; Jacoby, G.A., Chow, N., Waites, K.B., Prevalence of plasmid-mediated quinolone resistance (2003) Antimicrob Agents Chemother, 47, pp. 559-562; Wiegand, I., Luhmer-becker, I., Wiedemann, B., Effect of the plasmid encoded quinolone resistance determinant in P. stuartii on the selection of strains with clinical resistance to ciprofloxacin (2005), P1417 ECCMID. Copenhagen; Rice, L.B., Willey, S.H., Papanicolaou, G.A., Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility (1990) Antimicrob Agents Chemother, 34 (11), pp. 2193-2199; Wiener, J., Quinn, J.P., Bradford, P.A., Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes (1999) Jama, 10 (6), pp. 517-523; Abdalhamid, B., Pitout, J.D., Moland, E.S., Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada (2004) Antimicrob Agents Chemother, 48 (11), pp. 4435-4437; Pitout, J.D., Hanson, N.D., Church, D.L., Population-based laboratory surveillance for Escherichia coliproducing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes (2004) Clin Infect Dis, 15 (12), pp. 1736-1741; Laupland, K.B., Parkins, M.D., Ross, T., Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region (2007) Clin Microbiol Infect, 13 (7), pp. 683-688; Pitout, J.D., Gregson, D.B., Church, D.L., Population-based laboratory surveillance for AmpC beta-lactamaseproducing Escherichia coli, Calgary (2007) Emerg Infect Dis, 13 (3), pp. 443-448; Parkins, M.D., Gregson, D.B., Pitout, J.D., Population-based study of the epidemiology and the risk factors for Pseudomonas aerugi |
|